Animal models for arrhythmias.
暂无分享,去创建一个
[1] Shien-Fong Lin,et al. Mechanisms of Atrial Fibrillation , 2003, Journal of cardiovascular electrophysiology.
[2] S. Priori,et al. Bidirectional Ventricular Tachycardia and Fibrillation Elicited in a Knock-In Mouse Model Carrier of a Mutation in the Cardiac Ryanodine Receptor , 2005, Circulation research.
[3] S. Nattel,et al. Mechanisms of atrial remodeling and clinical relevance , 2005, Current opinion in cardiology.
[4] S. Varnous,et al. Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. , 2005, Human molecular genetics.
[5] J. Ruskin,et al. Integration of cardiac magnetic resonance imaging with three-dimensional electroanatomic mapping to guide left ventricular catheter manipulation: feasibility in a porcine model of healed myocardial infarction. , 2004, Journal of the American College of Cardiology.
[6] Jingdong Li,et al. Transgenic upregulation of IK1 in the mouse heart leads to multiple abnormalities of cardiac excitability. , 2004, American journal of physiology. Heart and circulatory physiology.
[7] A. Moorman,et al. Architectural plan for the heart: early patterning and delineation of the chambers and the nodes. , 2004, Trends in cardiovascular medicine.
[8] Walter Birchmeier,et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy , 2004, Nature Genetics.
[9] T. Jentsch,et al. Ion channels: Function unravelled by dysfunction , 2004, Nature Cell Biology.
[10] W. Birchmeier,et al. Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation , 2004, The Journal of cell biology.
[11] W. Haefeli,et al. Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] M. Casimiro,et al. Targeted point mutagenesis of mouse Kcnq1: phenotypic analysis of mice with point mutations that cause Romano-Ward syndrome in humans. , 2004, Genomics.
[13] M. Capecchi,et al. Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. , 2004, The American journal of pathology.
[14] C. Baty. Feline hypertrophic cardiomyopathy: an update. , 2004, The Veterinary clinics of North America. Small animal practice.
[15] Sander Verheule,et al. Increased Vulnerability to Atrial Fibrillation in Transgenic Mice With Selective Atrial Fibrosis Caused by Overexpression of TGF-β1 , 2004, Circulation research.
[16] Carlo Napolitano,et al. A cardiac arrhythmia syndrome caused by loss of ankyrin-B function , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Nerbonne. Studying cardiac arrhythmias in the mouse--a reasonable model for probing mechanisms? , 2004, Trends in cardiovascular medicine.
[18] C. Antzelevitch,et al. Autonomic aspects of arrhythmogenesis: the enduring and the new , 2004, Current opinion in cardiology.
[19] G. Koren. Electrical remodeling and arrhythmias in long‐QT syndrome: lessons from genetic models in mice , 2004, Annals of medicine.
[20] José Jalife,et al. Experimental and Clinical AF Mechanisms: Bridging the Divide , 2003, Journal of Interventional Cardiac Electrophysiology.
[21] Paul J. Wang,et al. Cardiac Conduction Abnormalities in a Mouse Model of Lyme Borreliosis , 2001, Journal of Interventional Cardiac Electrophysiology.
[22] Giuseppe Curigliano,et al. Drug-induced prolongation of the QT interval. , 2004, The New England journal of medicine.
[23] H. Niemann,et al. Application of transgenesis in livestock for agriculture and biomedicine. , 2003, Animal reproduction science.
[24] Gabriele Vacun,et al. Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia. , 2003, Toxicology and applied pharmacology.
[25] M. Biel,et al. The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Seidman,et al. Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiac hypertrophy and Wolff-Parkinson-White syndrome. , 2003, Journal of the American College of Cardiology.
[27] S. Taffet,et al. High Incidence of Cardiac Malformations in Connexin40-Deficient Mice , 2003, Circulation research.
[28] A. Waldo. Inter‐Relationships Between Atrial Flutter and Atrial Fibrillation , 2003, Pacing and clinical electrophysiology : PACE.
[29] M. Berridge,et al. Calcium signalling: dynamics, homeostasis and remodelling , 2003, Nature reviews. Molecular cell biology.
[30] A. Brown,et al. Role of the Cytosolic Chaperones Hsp70 and Hsp90 in Maturation of the Cardiac Potassium Channel hERG , 2003, Circulation research.
[31] S. Priori,et al. FKBP12.6 Deficiency and Defective Calcium Release Channel (Ryanodine Receptor) Function Linked to Exercise-Induced Sudden Cardiac Death , 2003, Cell.
[32] Ferhaan Ahmad,et al. Transgenic Mice Overexpressing Mutant PRKAG2 Define the Cause of Wolff-Parkinson-White Syndrome in Glycogen Storage Cardiomyopathy , 2003, Circulation.
[33] L. Mounkes,et al. A progeroid syndrome in mice is caused by defects in A-type lamins , 2003, Nature.
[34] M. Josephson,et al. Use of Electrogram Characteristics During Sinus Rhythm to Delineate the Endocardial Scar in a Porcine Model of Healed Myocardial Infarction , 2003, Journal of cardiovascular electrophysiology.
[35] Calum A. MacRae,et al. Drugs That Induce Repolarization Abnormalities Cause Bradycardia in Zebrafish , 2003, Circulation.
[36] H. Duff,et al. Selective Knockout of Mouse ERG1 B Potassium Channel Eliminates IKr in Adult Ventricular Myocytes and Elicits Episodes of Abrupt Sinus Bradycardia , 2003, Molecular and Cellular Biology.
[37] Lucas J Herfst,et al. Compound Heterozygosity for Mutations (W156X and R225W) in SCN5A Associated With Severe Cardiac Conduction Disturbances and Degenerative Changes in the Conduction System , 2003, Circulation research.
[38] A. Gramolini,et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death , 2003, Nature.
[39] S. Marx,et al. Leucine/isoleucine zipper coordination of ion channel macromolecular signaling complexes in the heart. Roles in inherited arrhythmias. , 2003, Trends in cardiovascular medicine.
[40] Knut Holthoff,et al. Absence epilepsy and sinus dysrhythmia in mice lacking the pacemaker channel HCN2 , 2003, The EMBO journal.
[41] Michel Haïssaguerre,et al. Distinctive Electrophysiological Properties of Pulmonary Veins in Patients With Atrial Fibrillation , 2002, Circulation.
[42] A. Wilde,et al. Absence of Calsequestrin 2 Causes Severe Forms of Catecholaminergic Polymorphic Ventricular Tachycardia , 2002, Circulation research.
[43] M. Cho,et al. Cardiac remodeling and atrial fibrillation in transgenic miceoverexpressing junctin , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] M. Allessie,et al. Electrical, contractile and structural remodeling during atrial fibrillation. , 2002, Cardiovascular research.
[45] Stanley Nattel,et al. Cellular electrophysiology of atrial fibrillation. , 2002, Cardiovascular research.
[46] J. Olgin,et al. Transgenic and knockout mouse models of atrial arrhythmias. , 2002, Cardiovascular research.
[47] M. Allessie,et al. Analysis of altered gene expression during sustained atrial fibrillation in the goat. , 2002, Cardiovascular research.
[48] Jamie I Vandenberg,et al. Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[49] J. Barhanin,et al. The multifaceted phenotype of the knockout mouse for the KCNE1 potassium channel gene. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.
[50] J. Seidman,et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. , 2002, The Journal of clinical investigation.
[51] S. Nattel. New ideas about atrial fibrillation 50 years on , 2002, Nature.
[52] S. Priori,et al. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia , 2002, Journal of cellular physiology.
[53] M. Allessie,et al. Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort. , 2002, Cardiovascular research.
[54] M. Allessie,et al. Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat. , 2001, Journal of molecular and cellular cardiology.
[55] J. Seidman,et al. Ventricular Arrhythmia Vulnerability in Cardiomyopathic Mice With Homozygous Mutant Myosin-Binding Protein C Gene , 2001, Circulation.
[56] J. Nerbonne,et al. Genetic Manipulation of Cardiac K+ Channel Function in Mice: What Have We Learned, and Where Do We Go From Here? , 2001, Circulation research.
[57] D. Roden,et al. Drug Block of I Kr : Model Systems and Relevance to Human Arrhythmias , 2001, Journal of cardiovascular pharmacology.
[58] J. Fish,et al. Electrical heterogeneity within the ventricular wall , 2001, Basic Research in Cardiology.
[59] B. London,et al. Cardiac Arrhythmias: From (Transgenic) Mice to Men , 2001, Journal of cardiovascular electrophysiology.
[60] Willem Flameng,et al. Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome , 2001, Nature Medicine.
[61] W. Manning,et al. Progressive atrioventricular conduction defects and heart failure in mice expressing a mutant Csx/Nkx2.5 homeoprotein. , 2001, The Journal of clinical investigation.
[62] D. Clapham,et al. Evaluation of the role of I(KACh) in atrial fibrillation using a mouse knockout model. , 2001, Journal of the American College of Cardiology.
[63] T. Schwarz,et al. The consequences of disrupting cardiac inwardly rectifying K+ current (IK1) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes , 2001, The Journal of physiology.
[64] R. Elston,et al. Sudden cardiac death, genes, and arrhythmogenesis: consideration of new population and mechanistic approaches from a National Heart, Lung, and Blood Institute workshop, Part II. , 2001, Circulation.
[65] A. Moorman,et al. Transgenic mice overexpressing human KvLQT1 dominant-negative isoform. Part I: Phenotypic characterisation. , 2001, Cardiovascular research.
[66] M. Rosen,et al. Altering Ventricular Activation Remodels Gap Junction Distribution in Canine Heart , 2001, Journal of cardiovascular electrophysiology.
[67] M. Franz,et al. Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange– Nielsen Syndrome , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[68] M. Sanguinetti,et al. Molecular and Cellular Mechanisms of Cardiac Arrhythmias , 2001, Cell.
[69] J. Seidman,et al. The Genetic Basis for Cardiomyopathy from Mutation Identification to Mechanistic Paradigms , 2001, Cell.
[70] Michael R. Rosen,et al. Pathophysiology and Prevention of Atrial Fibrillation , 2001, Circulation.
[71] S. Priori,et al. Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia , 2001, Circulation.
[72] R. Elston,et al. Sudden cardiac death, genes, and arrhythmogenesis : consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. , 2001, Circulation.
[73] A. Feinberg,et al. Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice. , 2000, The Journal of clinical investigation.
[74] P. J. Wang,et al. Connexin40‐Deficient Mice Exhibit Atrioventricular Nodal and Infra‐Hisian Conduction Abnormalities , 2000, Journal of cardiovascular electrophysiology.
[75] A. B. Brown,et al. A Novel Genetic Pathway for Sudden Cardiac Death via Defects in the Transition between Ventricular and Conduction System Cell Lineages , 2000, Cell.
[76] A. Camm,et al. Congenital and acquired long QT syndrome. , 2000, European heart journal.
[77] Mark T. Nelson,et al. Targeted disruption of Kir2.1 and Kir2.2 genes reveals the essential role of the inwardly rectifying K(+) current in K(+)-mediated vasodilation. , 2000, Circulation research.
[78] P. Douglas,et al. Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy , 2000, Nature Medicine.
[79] J. Nerbonne,et al. Rapid ventricular repolarization in rodents: electrocardiographic manifestations, molecular mechanisms, and clinical insights. , 2000, Journal of electrocardiology.
[80] M. Allessie,et al. Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. , 2000, Journal of molecular and cellular cardiology.
[81] J Jalife,et al. Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. , 2000, Circulation.
[82] J. Seidman,et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. , 1999, The New England journal of medicine.
[83] Moise Ns. Inherited arrhythmias in the dog: potential experimental models of cardiac disease. , 1999 .
[84] A. Wilde,et al. Homozygous premature truncation of the HERG protein : the human HERG knockout. , 1999, Circulation.
[85] A. Wilde,et al. Cardiac conduction defects associate with mutations in SCN5A , 1999, Nature Genetics.
[86] J. Dean,et al. Cardiac involvement in Emery Dreifuss muscular dystrophy: a case series , 1999, Heart.
[87] C. January,et al. Mechanism of block and identification of the verapamil binding domain to HERG potassium channels. , 1999, Circulation research.
[88] S Nattel,et al. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. , 1999, Circulation research.
[89] D. Housman,et al. DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. , 1999, The Journal of clinical investigation.
[90] C Antzelevitch,et al. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome. , 1999, Journal of electrocardiology.
[91] N. S. Moïse. Inherited arrhythmias in the dog: potential experimental models of cardiac disease. , 1999, Cardiovascular research.
[92] M. Boutjdir,et al. Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block in a murine model. , 1998, Journal of immunology.
[93] D. Escande,et al. Adult KCNE1-knockout mice exhibit a mild cardiac cellular phenotype. , 1998, Biochemical and biophysical research communications.
[94] T. Colatsky,et al. Inhibition of cardiac delayed rectifier K+ current by overexpression of the long-QT syndrome HERG G628S mutation in transgenic mice. , 1998, Circulation research.
[95] J Clémenty,et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.
[96] J Jalife,et al. Mechanisms of atrial fibrillation: mother rotors or multiple daughter wavelets, or both? , 1998, Journal of cardiovascular electrophysiology.
[97] G. Breithardt,et al. Experimental models of torsade de pointes. , 1998, Cardiovascular research.
[98] N. Peters,et al. Myocardial architecture and ventricular arrhythmogenesis. , 1998, Circulation.
[99] L. Widman,et al. Development and Validation of an ECG Algorithm for Identifying Accessory Pathway Ablation Site in Wolff‐Parkinson‐White Syndrome , 1998, Journal of cardiovascular electrophysiology.
[100] N. Matsuoka,et al. Characterization of stress-induced sudden death in cardiomyopathic hamsters. , 1998, The Journal of pharmacology and experimental therapeutics.
[101] Y. Murakami,et al. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[102] S Nattel,et al. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. , 1997, Circulation.
[103] N S Peters,et al. Mechanisms causing sustained ventricular tachycardia with multiple QRS morphologies: results of mapping studies in the infarcted canine heart. , 1997, Circulation.
[104] S Nattel,et al. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. , 1997, Circulation research.
[105] M. Russo,et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. , 1997, Circulation.
[106] M. Allessie,et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria. , 1997, Circulation.
[107] J. Seidman,et al. Electrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy mice. , 1997, The Journal of clinical investigation.
[108] Frederick J. Schoen,et al. A Mouse Model of Familial Hypertrophic Cardiomyopathy , 1996, Science.
[109] M. Allessie,et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.
[110] Douglas L. Jones,et al. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. , 1995, Circulation.
[111] B. H. Branham,et al. Anterior Septal Coronary Artery Infarction in the Canine: A Model of Ventricular Tachycardia With a Subendocardial Origin Ablation and Activation Sequence Mapping , 1994, Circulation.
[112] J. Ruskin,et al. Local activation variability during monomorphic ventricular tachycardia in the dog. , 1992, Cardiovascular research.
[113] David E. Housman,et al. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member , 1992, Cell.
[114] P B Corr,et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. , 1991, The Journal of thoracic and cardiovascular surgery.
[115] J M de Bakker,et al. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. , 1988, Circulation.
[116] B F Hoffman,et al. Atrial Reentry around an Anatomic Barrier with a Partially Refractory Excitable Gap: A Canine Model of Atrial Flutter , 1986, Circulation research.
[117] J. Ruskin,et al. Serial analysis of electrically induced ventricular arrhythmias in a canine model of myocardial infarction. , 1985, Journal of the American College of Cardiology.
[118] N. Kouchoukos,et al. Entrainment and Interruption of Atrial Flutter with Atrial Pacing: Studies in Man Following Open Heart Surgery , 1977, Circulation.
[119] T. N. James,et al. De subitaneis mortibus. XV. Hereditary stenosis of the His bundle in Pug dogs. , 1975, Circulation.
[120] T. K. Marshall,et al. De Subitaneis Mortibus: V. Occluded A‐V Node Artery , 1974, Circulation.
[121] D. Garcia-Dorado,et al. Cardiovascular Research , 1966 .